What is NDC 0591-2832?

0591-2832 is the product NDC for bexarotene, Bexarotene 75 mg/1 capsule, liquid filled, listed with the FDA by Actavis Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Actavis Pharma, Inc., NDC labeler code 0591. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for bexarotene?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

bexarotene NDC 0591-2832 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0591-2832Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00591-2832Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0591-2832-01	00591283201	100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-2832-01)Marketed from Nov 11, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): bexarotene
Generic name (nonproprietary): bexarotene
Active ingredients: Bexarotene — 75 mg/1
Dosage form: Capsule, Liquid filled
Route: Oral
Labeler: Actavis Pharma, Inc.NDC labeler code 0591
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209931
Marketing start: Nov 11, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 0591-2832_76dd1532-aa15-4e10-a26f-3cb25fbf8c1fSPL ID 76dd1532-aa15-4e10-a26f-3cb25fbf8c1fSPL set ID 3292c63c-052f-4f28-b739-530a86e660bfRxCUI 308725UNII A61RXM4375
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400591283201 followed by a unit qualifier and the quantity

Package 00591-2832-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 29, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Bexarotene capsules are indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. Bexarotene is a retinoid indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0591-2832

What is NDC 0591-2832?: 0591-2832 is the product NDC for bexarotene, Bexarotene 75 mg/1 capsule, liquid filled, listed with the FDA by Actavis Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: bexarotene.
What is the active ingredient?: Bexarotene.
Who is the labeler?: Actavis Pharma, Inc., NDC labeler code 0591. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for bexarotene?: 7 other product NDCs are listed under this name. See all bexarotene NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other bexarotene NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bexarotene	Bexarotene 75 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-380	31722-0380-01
Bexarotene	Bexarotene 75 mg/1	CapsuleOral	AvKARE	42291-072	42291-0072-01
Bexarotene	Bexarotene 10 mg/g	GelTopical	Amneal Pharmaceuticals NY LLC	69238-2088	69238-2088-06
Bexarotene	Bexarotene 75 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	69238-1250	69238-1250-01
Bexarotene	Bexarotene 75 mg/1	CapsuleOral	Upsher-Smith Laboratories, Inc.	0832-0285	00832-0285-00
Bexarotene	Bexarotene 75 mg/1	Capsule, Liquid filledOral	ANI Pharmaceuticals, Inc.	43975-315	43975-0315-10
Bexarotene	Bexarotene 75 mg/1	Capsule, Liquid filledOral	Mylan Pharmaceuticals Inc.	0378-6955	00378-6955-01